Device, a vision-language-action (VLA) foundation model designed to run locally on robot hardware. The model features ...

Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Research leaders from OpenAI, Anthropic, and Google DeepMind are urging tech companies and research groups to monitor AI's ...

The researchers argue that CoT monitoring can help researchers detect when models begin to exploit flaws in their training, ...

AlphaGenome, an artificial intelligence system just released by Google DeepMind in London, aims to show how even tiny changes ...

Nonprofit SaferAI analyzed risk management documents from major AI companies and found that none disclosed adequate safety preparations.

After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Scientists unite to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

No AI company scored better than “weak” in SaferAI’s assessment of their risk management maturity. The highest scorer was ...